UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Tracking expenses helps young adults see where money goes, identify unwanted habits, and start building a stronger financial foundation from day one.
21,975 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Keysight's Q2 2026 earnings transcript sheds light on demand, margins, and strategic priorities. This guide decodes t...
Nvidia’s quarterly print arrives amid an AI demand cycle that remains uneven. Analysts say nvidia earnings don’t matt...
When a company reports Q1 2026 results, the earnings call is where plans meet numbers. This guide explains how to rea...
In a hypothetical SpaceX IPO in 2026, Meta’s Mark Zuckerberg could emerge as the biggest winner, driven by AI investm...
Credo Technology posted a strong Q3 with revenue growth and new TAM expansions, even as margins face near-term pressu...
Workday is set to report Q1 earnings after the close tonight, the first quarter under its returning CEO. Analysts foc...
A retiree outlines a disciplined six-position income plan—three bond ETFs and three high-yield equities—to generate $...
Gas costs are lifting travel bills for Memorial Day weekend, with households facing higher pump prices and investors ...
With oil prices near a year high, IEO’s $0.55 quarterly dividend is set to be tested by producer payouts and market s...
As global tensions rise, borrowing costs and lenders' risk appetites shift. This guide explains why the housing marke...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...